189 related articles for article (PubMed ID: 22274556)
21. Polyamidoamine dendrimers with a modified Pentaerythritol core having high efficiency and low cytotoxicity as gene carriers.
Wang Y; Kong W; Song Y; Duan Y; Wang L; Steinhoff G; Kong D; Yu Y
Biomacromolecules; 2009 Mar; 10(3):617-22. PubMed ID: 19215068
[TBL] [Abstract][Full Text] [Related]
22. Cationic Dendrimers for siRNA Delivery: An Overview of Methods for In Vitro/In Vivo Characterization.
Laurini E; Aulic S; Marson D; Fermeglia M; Pricl S
Methods Mol Biol; 2021; 2282():209-244. PubMed ID: 33928579
[TBL] [Abstract][Full Text] [Related]
23. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
[TBL] [Abstract][Full Text] [Related]
24. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
25. Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing.
Posocco P; Liu X; Laurini E; Marson D; Chen C; Liu C; Fermeglia M; Rocchi P; Pricl S; Peng L
Mol Pharm; 2013 Aug; 10(8):3262-73. PubMed ID: 23841848
[TBL] [Abstract][Full Text] [Related]
26. Acetylation of PAMAM dendrimers for cellular delivery of siRNA.
Waite CL; Sparks SM; Uhrich KE; Roth CM
BMC Biotechnol; 2009 Apr; 9():38. PubMed ID: 19389227
[TBL] [Abstract][Full Text] [Related]
27. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action.
Dzmitruk V; Szulc A; Shcharbin D; Janaszewska A; Shcharbina N; Lazniewska J; Novopashina D; Buyanova M; Ionov M; Klajnert-Maculewicz B; Gómez-Ramirez R; Mignani S; Majoral JP; Muñoz-Fernández MA; Bryszewska M
Int J Pharm; 2015 May; 485(1-2):288-94. PubMed ID: 25796120
[TBL] [Abstract][Full Text] [Related]
28. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction.
Ionov M; Lazniewska J; Dzmitruk V; Halets I; Loznikova S; Novopashina D; Apartsin E; Krasheninina O; Venyaminova A; Milowska K; Nowacka O; Gomez-Ramirez R; de la Mata FJ; Majoral JP; Shcharbin D; Bryszewska M
Int J Pharm; 2015 May; 485(1-2):261-9. PubMed ID: 25791760
[TBL] [Abstract][Full Text] [Related]
29. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
31. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
[TBL] [Abstract][Full Text] [Related]
32. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.
Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391
[TBL] [Abstract][Full Text] [Related]
33. Novel lipoidal amine-based nanocarrier formulations for siRNA delivery.
Zhou C; Yue Z; Lee LJ; Lee RJ
Ther Deliv; 2012 Jun; 3(6):715-23. PubMed ID: 22838067
[TBL] [Abstract][Full Text] [Related]
34. Intrinsically fluorescent PAMAM dendrimer as gene carrier and nanoprobe for nucleic acids delivery: bioimaging and transfection study.
Tsai YJ; Hu CC; Chu CC; Imae T
Biomacromolecules; 2011 Dec; 12(12):4283-90. PubMed ID: 22029823
[TBL] [Abstract][Full Text] [Related]
35. Polyphenolic dendrimers as carriers of anticancer siRNA.
Grodzicka M; Michlewska S; Blasiak J; Ortega P; de la Mata FJ; Bryszewska M; Ionov M
Int J Pharm; 2024 Jun; 658():124199. PubMed ID: 38703928
[TBL] [Abstract][Full Text] [Related]
36. Cationic dendron-bearing lipids: investigating structure-activity relationships for small interfering RNA delivery.
Zhang Y; Chen J; Xiao C; Li M; Tian H; Chen X
Biomacromolecules; 2013 Dec; 14(12):4289-300. PubMed ID: 24144000
[TBL] [Abstract][Full Text] [Related]
37. Dendrimer Nanovectors for SiRNA Delivery.
Liu X; Peng L
Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447
[TBL] [Abstract][Full Text] [Related]
38. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery.
Lu JJ; Langer R; Chen J
Mol Pharm; 2009; 6(3):763-71. PubMed ID: 19292453
[TBL] [Abstract][Full Text] [Related]
39. Poly(amidoamine) Dendrimers Modified with 1,2-Epoxyhexane or 1,2-Epoxydodecane for Enhanced Gene Delivery Applications.
Xiao T; Cao X; Hou W; Peng C; Qiu J; Shi X
J Nanosci Nanotechnol; 2015 Dec; 15(12):10134-40. PubMed ID: 26682459
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
